EGFR Expression in Gallbladder Carcinoma in North Indian Population.
暂无分享,去创建一个
Puneet | M. Kumar | Vikas Kailashiya | Vikash
[1] P. Tiwari,et al. Clinical epidemiology of gallbladder cancer in North-Central India and association of immunological markers, NLR, MLR and PLR in the diagnostic/prognostic prediction of GBC. , 2021, Cancer treatment and research communications.
[2] A. Saha,et al. Role of EGFR and HER-2/NEU Expression in Gall Bladder Carcinoma (GBC) , 2021, Journal of Laboratory Physicians.
[3] Ying-bin Liu,et al. Overview of current targeted therapy in gallbladder cancer , 2020, Signal Transduction and Targeted Therapy.
[4] V. Kapoor,et al. Epidemiology of gallbladder cancer in India. , 2019, Chinese clinical oncology.
[5] G. Abou-Alfa,et al. Systemic therapy for gallbladder cancer. , 2019, Chinese clinical oncology.
[6] Hui Shen,et al. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway , 2019, Journal of Experimental & Clinical Cancer Research.
[7] Yu Fan,et al. EGFR Target Therapy Combined with Gemox for Advanced Biliary Tract Cancers: a Meta-analysis based on RCTs , 2018, Journal of Cancer.
[8] Sameer Gupta,et al. Investigation of targetable predictive and prognostic markers in gallbladder carcinoma. , 2018, Journal of gastrointestinal oncology.
[9] K. Rudresh,et al. Epidermal growth factor receptor: Role in human cancer , 2017, Indian journal of dental research : official publication of Indian Society for Dental Research.
[10] Zheng Wang,et al. The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR , 2016, Journal of experimental & clinical cancer research : CR.
[11] M. Khan,et al. Epidermal growth factor receptor expression in carcinoma gallbladder: A prospective study in Indian scenario. , 2016, Journal of cancer research and therapeutics.
[12] T. Goetze. Gallbladder carcinoma: Prognostic factors and therapeutic options. , 2015, World journal of gastroenterology.
[13] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[14] R. Artigiani-Neto,et al. EVALUATION OF P53, E-CADHERIN, COX-2, AND EGFR PROTEIN IMUNNOEXPRESSION ON PROGNOSTIC OF RESECTED GALLBLADDER CARCINOMA , 2014, Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery.
[15] H. Lenz,et al. S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma , 2014, British Journal of Cancer.
[16] C. Tzeng,et al. EGFR Nuclear Import in Gallbladder Carcinoma: Nuclear Phosphorylated EGFR Upregulates iNOS Expression and Confers Independent Prognostic Impact , 2012, Annals of Surgical Oncology.
[17] K. Mody,et al. Complete response in gallbladder cancer to erlotinib plus gemcitabine does not require mutation of the epidermal growth factor receptor gene: a case report , 2010, BMC Cancer.
[18] S. Kakar,et al. Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder. , 2010, Human pathology.
[19] A. Zhu,et al. Current management of gallbladder carcinoma. , 2010, The oncologist.
[20] B. Mehrotra,et al. EGFR Expression in Gallbladder Carcinoma in North America , 2008, International journal of medical sciences.
[21] P. Philip,et al. Phase II study of erlotinib in patients with advanced biliary cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] C. la Vecchia,et al. Gallbladder cancer worldwide: Geographical distribution and risk factors , 2006, International journal of cancer.
[23] Ying Feng,et al. [Significance of expression of epidermal growth factor (EGF) and its receptor (EGFR) in chronic cholecystitis and gallbladder carcinoma]. , 2003, Ai zheng = Aizheng = Chinese journal of cancer.
[24] C. S. Lee,et al. Epidermal growth factor receptor immunoreactivity in gallbladder and extrahepatic biliary tract tumours. , 1995, Pathology, research and practice.
[25] N. Husain,et al. EGFR and HER-2/neu Expression in Gallbladder Carcinoma: An Institutional Experience. , 2016, The Gulf journal of oncology.